» Articles » PMID: 39394725

Comparing the Effectiveness of Pregabalin and Gabapentin in Patients with Lumbar Radiculopathy: A Systematic Review and Meta-analysis

Overview
Journal Pain Pract
Specialties Neurology
Psychiatry
Date 2024 Oct 12
PMID 39394725
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gabapentinoids are commonly prescribed to control neuropathic pain of lumbar radiculopathy. Few trials have compared the efficacy of gabapentin (GBP) and pregabalin (PGB). Therefore, the authors conducted a meta-analysis to compare the difference in effect between GBP and PGB in lumbar radiculopathy patients.

Methods: Articles which were published between January 1, 1960 and May 31, 2023 were investigated via Cochrane Central Register of Controlled Trials, Embase, Google Scholar, and MEDLINE. This meta-analysis was conducted on patients with lumbar radiculopathy. Gabapentin was used as an intervention, and pregabalin as a comparison. As outcomes, pain rating scales including visual analog scale (VAS) and numeric pain rating scale (NRS), and number of adverse events (dizziness and sedation) were obtained.

Results: PGB showed statistically significant improvement in pain scale (VAS and NRS) in short-term follow-up (6 weeks or less) compared to GBP. (Total mean difference of -0.31) However, in the long-term follow-up (6 weeks to 12 weeks), there was no difference in pain reduction effect between two groups. The incidence of AEs showed no difference between two groups.

Conclusion: Based on this article, the existing evidence suggests that PGB was more effective in reducing pain of lumbar radiculopathy compared to GBP at the short-term follow-up, but there was no difference in the long-term follow-up. Physicians should consider this finding in prescribing medications for patients with lumbar radiculopathy.

Citing Articles

Comparing the effectiveness of pregabalin and gabapentin in patients with lumbar radiculopathy: A systematic review and meta-analysis.

Kwon D, Kim K, Kim D, Kwak S Pain Pract. 2024; .

PMID: 39394725 PMC: 11683178. DOI: 10.1111/papr.13424.

References
1.
Sills G . The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2005; 6(1):108-13. DOI: 10.1016/j.coph.2005.11.003. View

2.
Brozek J, Akl E, Compalati E, Kreis J, Terracciano L, Fiocchi A . Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011; 66(5):588-95. DOI: 10.1111/j.1398-9995.2010.02530.x. View

3.
Kwak S, Kwon J, Seo Y, Choi W . The effectiveness of acupuncture as an adjunctive therapy to oral pharmacological medication in patient with knee osteoarthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2023; 102(11):e33262. PMC: 10019238. DOI: 10.1097/MD.0000000000033262. View

4.
Wallin J, Cui J, Yakhnitsa V, Schechtmann G, Meyerson B, Linderoth B . Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur J Pain. 2002; 6(4):261-72. DOI: 10.1053/eujp.2002.0329. View

5.
Gammoh O, Al-Smadi A, Shawagfeh M, Abadi T, Kasawneh J, Malkawi S . The Clinical Difference between Gabapentin and Pregabalin: Data from a Pilot Comparative Trial. Rev Recent Clin Trials. 2021; 16(3):279-287. DOI: 10.2174/1574887116666210201110507. View